Grenoble, France

Gilles Gaillardon

This inventor holds 1 USPTO granted patent. Top assignee: Diabeloop. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gilles Gaillardon. Retrieved from https://idiyas.com/inventor/gilles-gaillardon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Gilles Gaillardon

Introduction

Gilles Gaillardon is a notable inventor based in Grenoble, France. He has made significant contributions to the field of medical technology, particularly in drug dosage determination. His work is characterized by a focus on improving patient safety and enhancing the efficiency of drug administration.

Latest Patents

Gilles Gaillardon holds a patent for a "Computerized system and method for the determination of a drug dosage, and computer program." This innovative system includes a dose determination module that calculates possible drug dosages. Additionally, it features a security module that assesses whether a security threshold is triggered. The notification module alerts users when a security threshold is breached, allowing for independent acknowledgment of notifications, regardless of the received drug dosage data. This patent exemplifies his commitment to advancing healthcare technology.

Career Highlights

Gilles Gaillardon is currently employed at Diabeloop, a company dedicated to developing innovative solutions for diabetes management. His role involves leveraging his expertise to create systems that enhance patient care. His work at Diabeloop reflects his dedication to improving medical technology and patient outcomes.

Collaborations

Gilles collaborates with Mathieu Cattelan, a fellow innovator in the field. Together, they work on projects that aim to push the boundaries of medical technology and improve drug delivery systems.

Conclusion

Gilles Gaillardon's contributions to the field of drug dosage determination highlight his innovative spirit and commitment to enhancing healthcare. His work continues to influence the medical technology landscape, making a significant impact on patient safety and care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…